RN7SL272P

Across TCGA pan-cancer cohorts, RN7SL272P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL272P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RN7SL272P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL272P is over-expressed in tumor, although a few such as COAD and STAD show the opposite, repressed pattern.

UCEC, COAD, and STAD are the cancer types where RN7SL272P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL272P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	+0.455	.033	2	view →
COAD	All	II,III,IV	−0.400	.035	2	view →
STAD	Male	All	−0.264	.011	2	view →
THCA	All	All	−0.026	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL272P–UCEC

Open the UCEC breakdown →